Skip to main content
OpenTrials
Completed

NCT Number: NCT05224011

Non-invasive Continuous Blood Pressure Monitoring

The Boppli device was designed to provide continuous non-invasive blood pressure (cNIBP) monitoring for infants, including neonates, in intensive care settings by detecting systolic, diastolic, and mean arterial blood pressure values comparable to that of an invasive arterial line (IAL) within published accuracy criteria. The device consists of an array of capacitive sensors contained in a soft, flexible, biocompatible band. It applies proprietary algorithms to capacitance detections to generate accurate systolic, diastolic, and mean arterial blood pressure and waveform data, then communicates the data to an external device via Bluetooth Low Energy for storage and display. It may be applied to the patient's arm or foot on either side of the body, which is advantageous for infants whose bodies provide limited surface area for medical devices or equipment. It does not require high skin pressure when correctly placed. The device is intended for single use of up to 72 hours and is discarded following use.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Age range

Up to 12 month

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Foothills Medical Center Neonatal Intensive Care Unit, NICU 51

Calgary, Alberta, T2N 4N1, Canada

About this study

The purpose of this study is to validate PyrAmes's non-invasive blood pressure measurements against invasive blood pressure measurements taken with a reference device that is routinely used in a hospital setting, is generally regarded as accurate, and is routinely used in the diagnosis and treatment of patients. In this case, the reference device is the invasive arterial line, which is routinely used in the care of infants in intensive care settings to collect accurate, continuous invasive blood pressure measurements.

The specific aim of this study is to record data obtained by use of the Boppli device, along with invasive measurements of blood pressure, for use in validating the Boppli device measurements and algorithm. The changes in capacitance will serve as an input for the Boppli algorithm and systolic, diastolic, and mean arterial pressure will be output. The measurements generated from the non-invasive Boppli Device will be validated against the invasive measurements from the reference device. This is a prospective, multi-center clinical study to validate the effectiveness of the Boppli Blood Pressure Monitor as compared to an invasive arterial reference. The study will evaluate the accuracy and precision of the Boppli system for continuous blood pressure monitoring by comparing SBP (systolic blood pressure), DBP (diastolic blood pressure), and MAP (mean arterial pressure) against the reference methodology.

Invasive arterial lines (IAL) were selected as the comparator for this study. IALs are the current gold standard for continuous blood pressure monitoring for infants in intensive care settings. Sphygmomanometers are widely used for non-invasive blood pressure monitoring among other populations but have documented issues with accuracy in patients with very low blood pressures, which includes many neonates and pediatric patients. Due to their potentially low accuracy in detecting blood pressure in infants, the manual sphygmomanometer is not regarded as an appropriate comparator for the Boppli device.

As stated in reference standards ISO 81060-2 and ANSI SP10, intra-arterial methods should not be used for subjects solely for the purpose of validating instrument performance. However, the SP10 standard states that in validation studies in children less than 3 years of age, the intra-arterial method should be used as the reference standard. In addition, it is noted that ISO 81060-2 explicitly states that children less than 3 years of age should not be included in clinical investigations using auscultatory reference readings. Therefore, this study will be conducted on clinical subjects (neonates/infants) in whom an intra-arterial line has already been placed for reasons other than validating instrument performance.

Primary objective: To assess the accuracy and precision of the Boppli system in measuring SBP, DBP, and MAP as compared to an invasive arterial line for continuous blood pressure monitoring.

Secondary Objective: To assess the safety of the Boppli system in a clinical setting.

Methods: Data to assess device efficacy, subject safety, and subject demographics will be collected from the Investigational sites. Data will be collected using an electronic data collection system (EDC) designed to comply with 21 CFR Part 11 and will be recorded into the electronic Case Report Form (eCRF). Primary source documentation will come directly from the subject's medical record

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Groups 1 - 4:

  • Pediatric patients less than 1 year of age and less than 5000 g in weight (primary target)
  • Requires intra-arterial blood pressure monitoring

Group 5:

  • Pediatric patients
  • Requires intra-arterial blood pressure monitoring

NOTE: Under no circumstance should an invasive arterial line be implanted in a patient due to this study, if not medically necessary.

Exclusion criteria

  • Skin conditions that limit the placement of the device
  • Patients connected to or treated by other devices that may alter the pulse waveform
  • Patients with a cardiac or vascular malformation that results in an abnormal waveform inappropriate to be considered a reference standard.

Treatment and study plan

Boppli Infant Blood Pressure Monitor

Device

The intervention is a medical device for the non-invasive measurement of blood pressure in infants

Primary outcomes

  1. Assess the accuracy and precision of the Boppli System in continuous blood pressure monitoring

    Time frame: 6 - 72 Hours

    The primary objective of this pivotal study is to assess the accuracy and precision of the Boppli system in measuring systolic blood pressure (SBP), diastolic blood pressure (DBP) and mean arterial pressure (MAP), as compared to an invasive arterial line for continuous blood pressure monitoring in infants.

    The following steps will be performed specifically to collect data for this study:

    • Boppli will be used alongside IALs onsite to collect blood pressure measurements, as well as pulse waveforms.
    • Continuous data from the IAL and Boppli will be paired for comparison
    • The total duration of data collection is expected to be approximately 6 hours with some patients remaining in the study up to 72 hours. However, subjects will not be required to remain in the study should clinical care indicate that the IAL should be removed.
    • Observed rapid changes in blood pressure will be collected and the Boppli's accuracy in detecting these changes will be compared against IAL

Secondary outcomes

  1. Assess the safety of the Boppli System in a clinical setting

    Time frame: 6 - 72 Hours

    The secondary objective is to assess the safety of the Boppli System in a clinical setting. This will be done by collecting and analyzing all adverse events observed during the study. Information on the usability of the device and its impact on workflow will also be collected.

    The following steps will be performed specifically to collect data for this study:

    • Boppli will be used alongside IALs onsite to collect blood pressure measurements, as well as pulse waveforms.
    • Continuous data from the IAL and Boppli will be paired for comparison
    • The total duration of data collection is expected to be approximately 6 hours with some patients remaining in the study up to 72 hours. However, subjects will not be required to remain in the study should clinical care indicate that the IAL should be removed.
    • Observed rapid changes in blood pressure will be collected and the Boppli's accuracy in detecting these changes will be compared against IAL

Sponsors and collaborators

Lead sponsor

PyrAmes Inc.

Industry

Collaborators

  • University of Calgary

Registry information

Official study title

A Prospective Study to Evaluate the Safety and Effectiveness of the Boppli™ in Measuring Mean Arterial Pressure (MAP), Systolic Blood Pressure (SBP), and Diastolic Blood Pressure (DBP) as Compared to an Invasive Arterial Reference

Important dates

Study start
2022
Primary completion
2022
Study completion
2022
First posted
Feb 4, 2022
Registry last updated
Mar 22, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.